Effect of preconceptional orlistat treatment on in-vitro fertilization outcome in overweight/obese women: study protocol for a randomized controlled trial
Abstract Background Obese women have fewer oocytes retrieved, an increased cancelation rate, a higher miscarriage rate, and a lower live birth rate after assisted reproductive technology (ART) treatment compared with women with normal weight. Weight loss before ART treatment can significantly improv...
Main Authors: | Jing Li, Ze Wang, Daimin Wei, Hong Liu, Jiangtao Zhang, Jianfeng Wang, Yuhua Shi, Zi-Jiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-018-2780-7 |
Similar Items
-
Demographic and clinical characteristics, and adverse reactions of people with overweight and obesity consumers of orlistat, attended by a call center (2009 – 2017)
by: Sandra Rizo Treviño
Published: (2018-10-01) -
ORLISTAT : Kan orlistat ha andra hälsoeffekter i kroppen förutom viktminskningseffekten?
by: Mohammadshahi, Faisal
Published: (2017) -
Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial
by: Wei Wang, et al.
Published: (2019-01-01) -
Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat
by: O.S. Payenok, et al.
Published: (2014-08-01) -
Evaluation of efficacy and safety of orlistat in obese patients
by: Suyog S Jain, et al.
Published: (2011-01-01)